Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) re (Q44138948)
Jump to navigation
Jump to search
scientific article published in October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) re |
scientific article published in October 2002 |
Statements
1 reference
Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) re (English)
1 reference
L B Hough
1 reference
J W Nalwalk
1 reference
R Stadel
1 reference
H Timmerman
1 reference
R Leurs
1 reference
B C Paria
1 reference
X Wang
1 reference
S K Dey
1 reference
1 October 2002
1 reference
1 reference
303
1 reference
1
1 reference
314-322
1 reference
Identifiers
1 reference
1 reference